The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial

Weller, Johannes; Zeyen, Thomas; Schaefer, Niklas; Schaub, Christina; Potthoff, Anna-Laura; Steinbach, Joachim P.; Hau, Peter; Seidel, Clemens; Goldbrunner, Roland; Tabatabai, Ghazaleh; Vatter, Hartmut; Tzaridis, Theophilos; Schneider, Matthias; Herrlinger, Ulrich

dc.contributor.author	Tabatabai, Ghazaleh
dc.date.accessioned	2024-02-28T10:21:38Z
dc.date.available	2024-02-28T10:21:38Z
dc.date.issued	2023
dc.identifier.issn	0167-594X
dc.identifier.uri	http://hdl.handle.net/10900/151394
dc.language.iso	en	en
dc.publisher	New York : Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s11060-023-04470-9
dc.subject.ddc	610	de_DE
dc.title	The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_00910
utue.publikation.seiten	749-755	de_DE
utue.personen.roh	Weller, Johannes
utue.personen.roh	Zeyen, Thomas
utue.personen.roh	Schaefer, Niklas
utue.personen.roh	Schaub, Christina
utue.personen.roh	Potthoff, Anna-Laura
utue.personen.roh	Steinbach, Joachim P.
utue.personen.roh	Hau, Peter
utue.personen.roh	Seidel, Clemens
utue.personen.roh	Goldbrunner, Roland
utue.personen.roh	Tabatabai, Ghazaleh
utue.personen.roh	Vatter, Hartmut
utue.personen.roh	Tzaridis, Theophilos
utue.personen.roh	Schneider, Matthias
utue.personen.roh	Herrlinger, Ulrich
dcterms.isPartOf.ZSTitelID	Journal of Neuro - Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	164	de_DE
utue.fakultaet	04 Medizinische Fakultät